−1.751SEK
−30.82 MSEK
155.00 KSEK
About 2CUREX AB
Sector
Industry
CEO
Kenneth Graabek Johansen
Website
Headquarters
Copenhagen
Founded
2006
ISIN
SE0010468124
FIGI
BBG00HYXTR29
2cureX AB engages in the research and development of anti-cancer treatments. It offers IndiTreat, which is a tool that determines treatment methods on individual colorectal cancer patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Copenhagen, Denmark.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2CUREX is 0.42 SEK — it has decreased by 15.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange 2CUREX AB stocks are traded under the ticker 2CUREX.
Yes, you can track 2CUREX AB financials in yearly and quarterly reports right on TradingView.
Like other stocks, 2CUREX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 2CUREX AB stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 2CUREX AB EBITDA is −37.16 M SEK, and current EBITDA margin is −23.98 K%. See more stats in 2CUREX AB financial statements.